Onxeo to attend Key Investor and Partnering Conferences in the Coming Months

Paris (France), September 13, 2018 – 05:45 pm CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO – FR0010095596), a clinical-stage biotechnology company specializing in the development of innovative drugs in oncology, today announced that its management team will attend the following key investor and partnering conferences in the coming months:

European Large & Midcap Event

October 8-9, 2018

Paris, France

 

BIO-Europe

November 5-7, 2018

Copenhagen, Denmark

 

Boursocap / Les Echos – Investir Event

November 21, 2018

Paris, France

 

Investor meetings during the JP Morgan Healthcare Conference 2019

January 7-10, 2019

San Francisco, US

 

BioMed Event

January 22, 2019

Paris, France

180913_Onxeo_conferences_Q418_EN